Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Antibodies, Monoclonal, Humanized"
journalStr:"Annals of the rheumatic diseases"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22&filter%5B%5D=journalStr%3A%22Annals+of+the+rheumatic+diseases%22&lookfor=%22%2AAntirheumatic+Agents%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22&filter%5B%5D=journalStr%3A%22Annals+of+the+rheumatic+diseases%22&lookfor=%22%2AAntirheumatic+Agents%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22&filter%5B%5D=journalStr%3A%22Annals+of+the+rheumatic+diseases%22&lookfor=%22%2AAntirheumatic+Agents%22&type=Subject
PubPharm (320)
1
IL-17A inhibitor-induced leucocytoclastic vasculitis is responsive to IL-23 blockade in a psoriatic arthritis patient
enthalten in:
Annals of the rheumatic diseases
| 2024
von
Binod, K.
|
Jabbour, A.
|
Poudel, P.
| +2
Wird geladen...
2
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies : a phase III randomised trial (contRAst 3)
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Taylor, P.
|
Weinblatt, M.
|
McInnes, I.
| +18
Wird geladen...
3
Correspondence on 'Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis : 16-week results from a randomized, placebo-controlled, phase 3 trial'
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Zhao, Y.
|
Huang, J.
CommentOn: Ann Rheum Dis. 2021 Aug;80(8):1014-1021. - PMID 33827787
Wird geladen...
4
Two cases with new onset of ANCA-positive eosinophilic granulomatosis with polyangiitis under treatment with dupilumab : coincidence or causality?
enthalten in:
Annals of the rheumatic diseases
| 2023
von
von Deimling, M.
|
Koehler, T.
|
Frye, B.
| +2
Wird geladen...
5
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis : results at week 104 from a randomised placebo-controlled withdrawal study
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Landewé, R.
|
Poddubnyy, D.
|
Rahman, P.
| +6
Wird geladen...
6
Correspondence on 'Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort' by Micheroli et al
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Huang, J.
|
Leong, P.
|
Wei, J.
CommentOn: Ann Rheum Dis. 2020 Sep;79(9):1203-1209. - PMID 32581090
Wird geladen...
7
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease : data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Khan, A.
|
Cole, A.
|
Bhadauria, N.
| +7
CommentOn: Ann Rheum Dis. 2020 Jul;79(7):859-866. - PMID 32471903
Wird geladen...
8
High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Conticini, E.
|
Franchi, F.
|
Bennett, D.
| +6
CommentOn: Ann Rheum Dis. 2020 Sep;79(9):1143-1151. - PMID 32719045
Wird geladen...
9
Response to : 'Comment on 'Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab'' by Pethoe-Schramm et al
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Shafran, I.
|
Alasti, F.
|
Smolen, J.
| +1
CommentOn: Ann Rheum Dis. 2020 Jul;79(7):874-882. - PMID 32371387
Wird geladen...
10
Comment on 'Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab'
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Pethoe-Schramm, A.
|
Devenport, J.
|
Reiss, W.
CommentOn: Ann Rheum Dis. 2020 Jul;79(7):874-882. - PMID 32371387
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Antibodies, Monoclonal, Humanized
Filter aufheben
Zeitschrift: Annals of the rheumatic diseases
Medienart
320
Aufsätze
285
E-Artikel
285
E-Ressourcen
35
Gedruckte Aufsätze
Zeitschriftentitel
Annals of the rheumatic diseases
Thema
Antibodies, Monoclonal, Humanized
312
Antirheumatic Agents
254
Journal Article
206
Research Support, Non-U.S. Gov't
168
Adalimumab
168
FYS6T7F842
165
Antibodies, Monoclonal
140
Tumor Necrosis Factor-alpha
106
Randomized Controlled Trial
93
I031V2H011
93
tocilizumab
89
Methotrexate
88
YL5FZ2Y5U1
83
Multicenter Study
81
Immunoglobulin G
78
Etanercept
78
OP401G7OJC
77
Receptors, Tumor Necrosis Factor
76
B72HH48FLU
76
Infliximab
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
44
2020-
210
2010-2019
62
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
320
Englisch
Haven't found what you're looking for?
Wird geladen...